January 12, 2012
A newly published clinical trial result reports treating Type 1 diabetics T-Cells with umbilical cord blood stem cells helped restart pancreatic function and insulin production. The process is called “re-education” as the newly introduced T-Cells improved the behavior of the patients own T-Cells. The study recruited 15 Type 1 diabetic patients, twelve of which had [...]
Read the full article →
November 11, 2011
HEMACORD(TM), a umbilical cord blood product, has been approved by the Food and Drug Administration for allogeneic hematopoietic stem cell transplantation, the first such approval of a stem cell product in the world. “The use of cord blood hematopoietic progenitor cell therapy offers potentially life-saving treatment options for patients with these types of disorders,” said [...]
Read the full article →